EcoDrugPlus

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSOKIG00005022191
Gene Symbol: MCL1B
1 Cross references
152 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSOKIG00005044412
Gene Symbol: MDM2
3 Cross references
281 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae)

Ensembl ID : ENSOKIG00005009347
Gene Symbol: MLST8
1 Cross references
199 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSOKIG00005012906
Gene Symbol: NAALAD2
1 Cross references
340 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSOKIG00005020028
Gene Symbol: LOC109885081
3 Cross references
179 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSOKIG00005030807
Gene Symbol: LOC109885081
3 Cross references
179 Possible Orthologues:

Nad-Dependent Protein Deacetylase Sirtuin-1

Ensembl ID : ENSOKIG00005001697
Gene Symbol: LOC109889761
2 Cross references
151 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSOKIG00005017077
Gene Symbol: NPC1L1
3 Cross references
189 Possible Orthologues:

Nt-3 Growth Factor Receptor-Like

Ensembl ID : ENSOKIG00005045529
Gene Symbol: LOC109867469
3 Cross references
140 Possible Orthologues:

Nt-3 Growth Factor Receptor-Like

Ensembl ID : ENSOKIG00005031153
Gene Symbol: LOC109889245
3 Cross references
140 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSOKIG00005011053
Gene Symbol: LOC109905971
3 Cross references
187 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSOKIG00005022936
Gene Symbol: LOC109880678
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).